Diatranz Otsuka's Acquisition

Diatranz Otsuka was acquired by Otsuka Holdings on January 25, 2018.

Diatranz Otsuka uses the biological similarities between humans and other mammals to develop cellular therapies to improve the lives of people living with serious diseases.…

Articles about Diatranz Otsuka's Acquisition: